Warehouse Overstock Promotion |  Save 10%  on Premium Lab Supplies |  Shop Now

Menu

This product has been added to the cart.

Recombinant Mouse EGFR Protein (Fc Tag)(Active)

SKU: PKSM040366-100

  • $ 86495


Request a Quote

Recombinant Mouse EGFR Protein (Fc Tag)(Active)

 

SKU # PKSM040366
Expression Host HEK293 Cells

 

 

Description

Synonyms 9030024J15Rik, AI552599, Erbb, Errb1, Errp, Wa5, wa-2, wa2
Species Mouse
Expression Host HEK293 Cells
Sequence Met 1-Ser 647
Accession Q01279
Calculated Molecular Weight 96.0 kDa
Observed Molecular Weight 130 kDa
Tag C-hFc
Bio-activity Measured by its ability to bind human EGF in a functional ELISA.
  

 

Properties

Purity > 90 % as determined by reducing SDS-PAGE.
Endotoxin < 1.0 EU per μg of the protein as determined by the LAL method.
Storage Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping This product is provided as lyophilized powder which is shipped with ice packs.
Formulation Lyophilized from sterile PBS, pH 7.4
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Reconstitution Please refer to the printed manual for detailed information.


Background

As a member of the epidermal growth factor receptor (EGFR) family, EGFR protein is type I transmembrane glycoprotein that binds a subset of EGF family ligands including EGF, amphiregulin, TGF-&alpha;, betacellulin, etc. EGFR protein plays a crucial role in signaling pathway in the regulation of cell proliferation, survival and differentiation. Binding of a ligand induces EGFR protein homo- or heterodimerization, the subsequent tyrosine autophosphorylation and initiates various down stream pathways (MAPK, PI3K/PKB and STAT). In addition, EGFR signaling also has been shown to exert action on carcinogenesis and disease progression, and thus EGFR protein is proposed as a target for cancer therapy currently.